Board summary
Key figures
53,976
Registered population
57.3% aged 18–64
24.9%
Aged 65+
ICB 21.9% · England 17.9%
2.4%
Ethnic minority (non-White)
1.4% Asian · England 9.6%
24.8%
In IMD quintile 1
ICB 9.2% · England 21.0%
~12,832
Core20 residents (est.)
Resident basis; registered basis ~13,429 · see page 3
10,306
Hypertension register
+4.29% in 3 yrs · England +5.60%
876
SMI register
54.1% of Eastbourne's
1,395
COPD register
Reviews -1.90% in 3 yrs
Forecast to 2030
11,844
Hypertension patients, 2030
+1,538 on today
68.8%
QRISK ≥20% on statins, 2030
+3.55pp over 3 yrs
6.3%
Cancer prevalence, 2030
England 4.5%
Three things the board should see
Under-80 BP control fell behind England.
Under-80 hypertension BP control fell 5.6% over three years to 57.9%, sitting 10.0 percentage points below England (67.8%, +3.2%).
SMI physical health checks lag England.
Annual SMI checks trail England across BMI recording at 67.0% (England 82.1%), alcohol recording at 68.1% (81.8%) and BP checks at 72.4% (83.4%).
Three-year asthma review growth outpaced England.
Recorded 12-month asthma reviews rose +13.0% (+5.7 pp) over three years against England's +4.4% (+2.8 pp), though coverage remains 49.7% (England 65.7%).
Population, age and ethnicity
Aged 65+ patients comprise 24.9% of the list, 7.0 percentage points above England
ALPS GROUP PCN registers 53,976 patients across four practices. Patients aged 65+ comprise 24.9% (13,441), above Eastbourne (24.2%), NHS Sussex Integrated Care Board (21.9%) and England (17.9%). The 18–64 band represents 57.3% (Eastbourne 58.6%, NHS Sussex Integrated Care Board 60.5%, England 62.7%) and ages 0–17 represent 17.8% (Eastbourne 17.2%, NHS Sussex Integrated Care Board 17.7%, England 19.6%). List growth to 2030 is projected at 3.0% (Eastbourne 1.1%, NHS Sussex Integrated Care Board 2.1%, England 2.3%; unverified methodology). Census area estimates show 97.6% White and 2.4% ethnic minorities; Census resident bases differ from registered lists.
Age profile
65+: ICB 21.9%, England 17.9%
Ethnicity
Older people · falls rows are Eastbourne local-authority (LA) data, not PCN
| Measure | Local | South East | England | Period |
|---|---|---|---|---|
| Falls admissions, 65+, per 100,000 (Eastbourne LA) | 2,325 | 2,018 | 1,958 | 2024/25 |
| Diabetes with frailty: HbA1c ≤75 mmol/mol (PCN) | 79.6% | 82.2% | 81.9% | 2024/25 |
| Diabetes without frailty: HbA1c ≤58 mmol/mol (PCN) | 56.4% | 57.8% | 57.4% | 2024/25 |
| Falls admissions, 65 to 79, per 100,000 (Eastbourne LA) | 1,221 | 981 | 955 | 2024/25 |
| Falls deaths, all ages, per 100,000 (Eastbourne LA) | 7.7 | 14.0 | 14.8 | 2022‑24 |
Deprivation and Core20
Core20 deprivation affects 24.8% of patients and spans 31.2 percentage points across practices
Core20 patients represent 24.8% of the PCN list, above Eastbourne (19.5%), NHS Sussex Integrated Care Board (9.2%) and England (21.0%). Practice rates span 31.2 percentage points, from 6.0% at Arlington Road Surgery to 37.2% at Seaside Medical Centre. Three practices exceed England: Seaside Medical Centre holds the highest concentration (37.2%, 4,314 patients) while Park Practice holds the largest volume (34.4%, 4,548 patients). Modelled practice estimates do not sum to the 12,832 resident estimate. Targeted outreach could address concentrated deprivation at the two leading practices first.
% of patients in IMD quintile 1, by practice
Dashed line: England 21.0% · right column: Core20 patients, registered basis
PLUS groups and inclusion health
PLUS groups and inclusion health
876
SMI register
1.59% recorded prevalence
518
Learning disability register
0.94% recorded prevalence
70
Care homes, 2,193 beds
In the PCN catchment
9.7%
Provide unpaid care
Eastbourne, Census 2021
The PCN records 876 severe mental illness patients (1.6%; Eastbourne 1.5%, NHS Sussex Integrated Care Board 1.1%, England 1.0%) and 518 on learning disability (0.9%; Eastbourne 0.8%, NHS Sussex Integrated Care Board 0.6%, England 0.6%). Catchment care homes comprise 70 sites with 2,193 beds.
Severe mental illness: physical health checks
Recorded severe mental illness prevalence is 1.6% (England 1.0%). Annual physical checks trail England: blood pressure recording is 72.4% (England 83.4%) and BMI recording is 67.0% (England 82.1%).
Clinical focus: hypertension and lipids
Clinical focus: hypertension and lipids
10,306
Hypertension register
+4.29%
Register growth, 3 yrs
Eastbourne +5.24% · England +5.60%
−3.45pp
BP control, under 80
≤140/90 · −0.30pp aged 80+
+1,538
More patients by 2030
Forecast 11,844 (20.35%)
Hypertension case-finding and control
Recorded hypertension prevalence is 18.7% (10,306 patients), above Eastbourne (17.5%), NHS Sussex Integrated Care Board (16.3%) and England (15.2%). While 85.7% of patients have a recent blood pressure reading (England 90.0%), control in patients aged under 80 fell 5.6% over three years to 57.9%, trailing Eastbourne (60.5%), the ICB (66.8%) and England (67.8%, which rose +3.2%). Control for aged 80 and over also trails at 75.5% (England 81.2%). This widening control shortfall despite high monitoring could reflect delays in treatment titration, which a local clinical audit would test. Under-80 blood pressure control is well below national and system comparators, meaning the PCN should prioritise structured medication titration and follow-up across its recorded hypertensive cohort.
Lipids and statins
Lipid-lowering therapy reaches 61.0% of patients with QRISK ≥ 20%, below England (63.6%) but above NHS Sussex Integrated Care Board (60.0%), while treatment among CKD patients is 63.9% (England 70.3%). Fewer high-risk primary prevention and CKD patients receive lipid therapy than nationally, indicating an opportunity to prioritise systematic recall and initiation.
| Measure | Items | Cost / item | ICB | England | Annual spend |
|---|---|---|---|---|---|
| Lipid-modifying, 2026 | 103,578 | £2.20 | £2.42 | £1.86 | £227,872 |
| Cardiovascular (all), 2025 | 149,841 | £3.05 | £3.32 | £3.33 | £457,015 |
In 2026, the PCN prescribed 103,578 lipid-regulating items at £2.20 per item (spend £227,872), compared with £1.86 in England and £2.42 in NHS Sussex Integrated Care Board. This was £35,217 more than at England's unit cost. Higher unit costs than England indicate potential scope to review lipid-modifying formulary choices while sustaining treatment reach.
Clinical focus: respiratory, cancer register and children
Clinical focus: respiratory, cancer register and children
Respiratory
+13.00%
Asthma reviews, PCN 3-yr % change
+4.44%
Asthma reviews, England 3-yr % change
−0.38%
Asthma prevalence, PCN 3-yr % change
Asthma prevalence is 7.6% (3,996 patients) against 6.6% in England, with asthma prescribing at 1,973 items per 1,000 aged 5–19 (England 1,488). Despite a +13.0% (+5.7 pp) three-year rise, only 49.7% of asthma patients had a 12-month review (England 65.7%), leaving an unreviewed scale gap of about 2,000 patients. COPD prevalence is 2.5% (England 1.9%), yet 12-month reviews reach 68.4% (England 76.4%). Slower review delivery alongside higher prescribing could reflect follow-up capacity constraints, which local audit would test.
Cancer register and children's immunisation
Recorded cancer prevalence is 5.6% (3,059 patients; England 3.8%). In childhood immunisation, MMR dose 1 coverage at 24 months is 86.4% (England 88.3%, NHS Sussex ICB 90.2%), falling 8.6 pp below the 95.0% target. At age 5, PCN coverage is 93.7% for MMR dose 1 but 87.4% for MMR dose 2 (a 6.3 pp gap).
Dashed line: 95% national coverage target · solid tick: England
Early cancer diagnosis
Early cancer diagnosis
58.5%
Sussex ICB, stage 1–2
55.3%
England, 2022
75%
National ambition by 2028
~1,360
Extra early-stage cases a year to reach the ambition
| Stage 1–2 share by cancer type, 2022 | Sussex ICB | England | No usable stage | Staged cancers |
|---|---|---|---|---|
| Prostate | 56.6% | 53.2% | 19% | 1,668 |
| Breast | 86.1% | 85.4% | 23% | 1,400 |
| Bowel | 49.8% | 47.0% | 26% | 1,133 |
| Lung | 30.3% | 33.8% | 15% | 1,058 |
| Skin cancer | 95.3% | 87.8% | 17% | 698 |
In 2022, NHS Sussex ICB diagnosed 58.5% of staged cancers at stage 1 or 2 (England 55.3%), sitting 16.5 pp below the 75.0% national ambition by 2028, with known-stage completeness at 64.3% across 12,766 registered cases. These system figures do not measure PCN performance. At PCN level, cervical screening coverage at ages 25-49 is 65.7% (England 66.8%, NHS Sussex Integrated Care Board 68.6%), falling 5.0% over three years (England -1.0%), and reaching 61.1% at The Lighthouse Medical Practice. Breast screening coverage trails at 67.1% (England 69.9%). Primary care screening recall remains central to earlier detection.
Cancer waits, diagnostics and community services
Cancer waits, diagnostics and community services
Cancer waits and diagnostics, Jul 2026 (provisional)
In provisional Jul 2026 data, East Sussex Healthcare NHS Trust met the 28-day faster diagnosis standard at 84.2% (standard 75.0%; Maidstone and Tunbridge Wells NHS Trust 81.8%, England 79.3%, University Hospitals Sussex NHS Foundation Trust 74.0%) and 31-day treatment at 98.2% (standard 96.0%). However, 62-day treatment reached 67.0%, below the 85.0% standard, England (71.2%) and NHS Surrey and Sussex Integrated Care Board (71.5%). Diagnostic 6+ week waits across all diagnostic tests stood at 5.3% (England 23.1%), while echocardiography was 21.9%. These provider figures reflect acute pressure rather than PCN-specific pathways.
| Pathways within standard (%) | East Sussex Healthcare | Sussex | Maidstone and Tunbridge Wells | Surrey and Sussex ICB | England |
|---|---|---|---|---|---|
| 28-day faster diagnosis (75%) | 84.20 | 74.01 | 81.78 | 79.29 | 79.32 |
| 31-day treatment (96%) | 98.19 | 76.79 | 98.35 | 90.45 | 92.50 |
| 62-day referral to treatment (85%) | 67.04 | 65.20 | 87.43 | 71.51 | 71.16 |
| Diagnostic waits over 6 weeks (%) | East Sussex Healthcare | Sussex | Maidstone and Tunbridge Wells | England |
|---|---|---|---|---|
| MRI | 6.48 | 5.62 | 0.92 | 21.40 |
| CT | 0.48 | 8.57 | 0.51 | 9.92 |
| Echocardiography | 21.94 | 0.39 | 2.57 | 28.48 |
| Colonoscopy | 0.74 | 39.35 | 19.80 | 30.83 |
| Gastroscopy | 0.31 | 20.02 | 24.03 | 29.02 |
| All 15 DM01 tests | 5.27 | 12.95 | 6.42 | 23.14 |
| Community services activity | East Sussex residents | Surrey and Sussex ICB |
|---|---|---|
| Care contacts | 100,740 | 309,615 |
| Referrals | 17,285 | 66,930 |
| Patients with a contact | 25,880 | 85,660 |
Community services (residents of East Sussex), Jun 2026 (provisional). In Jun 2026 (provisional), contacts with adults aged 65+ accounted for 68% of Eastbourne residents' community health service contacts (68,465 of 100,740). This borough-level activity reflects resident use rather than registered PCN patients. Coordinated primary and community care remains vital for older patients.
Practice variation and patient experience
Practice variation and patient experience
Clinical QOF achievement reaches 99.2% to 100.0% across all four practices (England 97.1%). In vaccination, Arlington Road Surgery reached 36.6% (England 55.2%) while Seaside Medical Centre reached 100.0%, a 63.4 pp range. All-domain personalised care adjustments span 10.5% at Arlington Road Surgery to 14.0% at Seaside Medical Centre (England 10.0%), which may indicate that high points mask delivery variation.
GP Patient Survey by practice
| Practice | Responses | % in IMD Q1 | Phone easy | Request led to appt | Overall good |
|---|---|---|---|---|---|
| Seaside | 97 | 37.2 | 61.0% | 72.2% | 92.5% |
| Arlington Road | 131 | 6.0 | 71.9% | 80.6% | 87.5% |
| Park Practice | 95 | 34.4 | 27.4% | 71.4% | 72.6% |
| Lighthouse | 111 | 22.4 | 43.6% | 64.6% | 70.1% |
| England | — | ~21 | 56.9% | 71.6% | 76.7% |
Where the PCN lags
Twenty of 25 measures trail England over three years despite asthma review gains
Across 25 tracked measures, 20 trail England's three-year change. The widest relative lags appear in under-80 blood pressure control, falling 5.6% (England +3.2%), and 12-month heart failure reviews, rising 0.4% (England +8.7%). Severe mental illness body mass index recording fell 0.4 pp over three years (England +5.1 pp). Conversely, three-year relative gains outpaced England for asthma reviews (+13.0% vs +4.4%) and learning disability prevalence (+13.2% vs +5.4%). Current levels remain mixed, as asthma reviews reach 49.7% against England's 65.7%.
3-year change · PCN vs England
Bars show the direction and scale of relative change. Orange: PCN · Grey: England.
BP control, under 80
Heart failure reviews
Hypertension treated to target
BMI record (SMI)
Dementia register
Asthma reviews
Breast screening (53-70)
What the data can't tell us: gaps and local assets
What the data can't tell us: gaps and local assets
| Local assets and voluntary sector | PCN | Eastbourne | Asset | PCN | Eastbourne |
|---|---|---|---|---|---|
| Care homes (catchment) | 70 (2,193 beds) | n/a | Schools (catchment) | 67 | n/a |
| Children's centres | 2 | 2 | Places of worship | 55 | 46 |
| Libraries | 3 | 3 | Homelessness support (VCS) | 0 | no data |
| Day centres (VCS) | 1 | 1 | Carers support groups (VCS) | 1 | 1 |
| Primary schools (LA maintained) | 10 | 8 | Primary academies | 21 | 22 |
| Special schools | 1 | 1 |
0 = the source returned zero. n/a = not held at this level. No data = no value returned; this does not mean zero.
Options for the PCN
Options for the PCN
Each option in full
Option 1
Structured asthma review recall
On the 3,996 asthma register, 49.7% had a 12-month review (Eastbourne 52.3%, ICB 62.5%, England 65.7%), a scale gap of about 2,000 patients despite a +13.0% (+5.7 pp) three-year rise. For discussion: the PCN could run structured asthma recall using a single review template at Core20-concentrated practices first. Moderate effort to run.
Evidence base: the annual asthma review is the process gap between the register and outcomes.
Policy anchor: Core20PLUS5 chronic respiratory disease priority.
Option 2
Under-80 hypertension titration review
Among 10,306 hypertension patients (18.7%), under-80 blood pressure control (<= 140/90 mmHg) fell 5.6% (3.5 pp) over three years to 57.9%, trailing Eastbourne (60.5%), ICB (66.8%) and England (67.8%). For discussion: the PCN could run pharmacist-led or nurse-led titration clinics for registered under-80 patients above target. Moderate effort to run.
Evidence base: the hypertension register is the cohort for case-finding, blood-pressure control and AF anticoagulation; its size and growth set the workload those interventions must cover, and a shortfall in control shows up later as emergency admission.
Policy anchor: Core20PLUS5 (hypertension case-finding and optimal management); NHS CVD ambitions to 2029 on detection, treatment to target and statins for high-risk patients (CVDPREVENT).
Option 3
Combined SMI physical health checks
Across 876 SMI patients (1.6%; 54.1% of Eastbourne's register), 12-month BMI recording is 67.0% (England 82.1%), alcohol recording 68.1% (England 81.8%) and BP checks 72.4% (England 83.4%). For discussion: practices could book combined physical check appointments, audit partial-check coding, and raise shared recording pathways with mental health partners. Moderate effort to run.
Evidence base: the SMI register is the cohort for the annual physical health check; the alcohol record is the delivery measure for alcohol screening and brief intervention.
Policy anchor: Mental Health Investment Standard; NHS alcohol care teams and the From Harm to Hope strategy.
Provenance and audit trail
Provenance and audit trail
Figures are the profile's, drawn from Coplug indicator tables: census, deprivation and QOF measures, MHCLG, Rough sleeping snapshot in England: autumn 2025, OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713) and OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002). Every recommended action and option is the profile's own; the evidence-base statements that support them — what each register is the cohort for, and the national policy it serves — are quoted from Coplug's indicator catalogue. No recommendation in this report is authored outside the profile and that catalogue. ICB- and provider-level data (page 8) describes the system the PCN sits in and is not read as PCN performance.
| Recommendation | Indicator(s) | Policy anchor | Data level |
|---|---|---|---|
| Older adult service planning (p2) | Aged 65+ | Neighbourhood health framework · NHS vaccination strategy | PCN |
| Targeted Core20 clinical outreach (p3) | Core20 cohort (IMD quintile 1) | Core20PLUS5 · 10YHP equity test | PCN |
| SMI physical check recall audit (p4) | SMI register with a BMI recorded in the last 12 months | MHIS · From Harm to Hope | PCN |
| Hypertension treatment titration audit (p5) | Last BP reading of patients (<80 yrs with hypertension) in the last 12 months is <= 140/90 mmHg (denominator incl. PCAs) | Core20PLUS5 CVD · CVDPREVENT 2029 | PCN |
| Preschool booster and MMR recall (p6) | MMR dose 1 coverage at 24 months | 10YHP sickness to prevention · 95% target | PCN |
| Cervical screening recall audit (p7) | Women (25-49 yrs) with a record of cervical screening in the last 3.5 yrs (denominator incl. PCAs) | Fit for the Future: 10 Year Health Plan for England · Medium Term Planning Framework 2026 | PCN |
| Option 1 · Structured asthma review recall (p12) | Asthma register · Asthma: QOF prevalence · Patients with Asthma: review in the last 12 months (denominator incl. PCAs) | Core20PLUS5 respiratory | PCN |
| Option 2 · Under-80 hypertension titration review (p12) | Hypertension register · Hypertension: QOF prevalence · Hypertension patients with a recent BP reading | Core20PLUS5 CVD · CVDPREVENT 2029 | PCN |
| Option 3 · Combined SMI physical health checks (p12) | Severe mental illness register · Severe mental illness: QOF prevalence · SMI register with a BP check in the last 12 months | MHIS · From Harm to Hope | PCN |
Data sources
Data sources
Every figure in this profile comes from a dataset below, at the level and period stated. Nothing published above PCN level is read as PCN performance.
| Dataset | Level | Period | Used for |
|---|---|---|---|
| Coplug indicator tables: census, deprivation and QOF measures | PCN & Practice | 2023 to 2025, projected to 2030; 2023 to 2024 | Pages 1, 2, 3, 4, 5, 6, 7, 8, 10, 12 |
| MHCLG, Rough sleeping snapshot in England: autumn 2025 | Local authority | Autumn 2025 | Pages 2, 4 |
| OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713) | PCN | 2024/25 | Pages 2, 4 |
| OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002) | Local authority | 2024/25; 2022-24 | Pages 2, 4 |
| ONS, Census 2021 TS039: provision of unpaid care (age-standardised) | Local authority | Census 2021 | Pages 2, 4 |
| QOF registers, prevalence and care processes (Coplug indicator tables) | Practice | 2023 to 2025, projected to 2030 | Pages 4, 5, 6, 7, 8, 10 |
| UKHSA, COVER supplementary GP data, childhood immunisation coverage, Q1 2025/26 | PCN & Practice | Q1 2025/26 | Pages 4, 6 |
| UKHSA, Seasonal influenza vaccine uptake in GP patients, 2025 to 2026 | ICB | 2025/26 season to 28 Feb 2026 | Pages 4, 6 |
| NHS England, Cancer Waiting Times: July 2026 monthly time series with revisions | ICB & Provider | Jul 2026 (provisional) | Pages 7, 8 |
| NHS England, Community Services Statistics (CSDS): June 2026 provisional experimental data | ICB & Local authority | Jun 2026 (provisional) | Pages 7, 8 |
| NHS England, Monthly Diagnostics Waiting Times and Activity (DM01): provider by test, July 2026 | Provider | Jul 2026 | Pages 7, 8 |
| National Disease Registration Service, Stage at diagnosis by cancer site in England, 2013 to 2022 | ICB | 2022 | Pages 7, 8 |
| NHS England / Ipsos, GP Patient Survey 2026: practice results (weighted) | Practice | Survey Jan-Apr 2026 | Page 9 |
| NHS England, Quality and Outcomes Framework 2025-26: achievement by practice and domain | Practice | 2025/26 | Page 9 |
| NHS England, Quality and Outcomes Framework 2025-26: personalised care adjustments by practice and domain | Practice | 2025/26 | Page 9 |
| Coplug indicator catalogue — definitions, cohorts, policy anchors | Reference | Current | Evidence-base lines, page 13 |
Methods, data-quality notes and limitations
Methods, data-quality notes and limitations
Methods
Estimated gaps apply benchmark prevalence to the registered population and subtract the recorded register. They size the task; they are not confirmed missed patients.
Percentage points are the difference between two rates; a relative change is that difference as a share of the starting rate. Register changes are relative, over three years.
Forecasts to 2030 extend each indicator's current trajectory with no change in case-finding or service model: a baseline to act against, not a prediction.
Core20 is the most deprived 20% nationally (IMD quintile 1). Practice shares are not additive to the PCN figure. Ethnic minority is 100% minus White. Local-authority averages are unweighted.
